Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: A report from the Childhood Cancer Survivor Study (CCSS) Meeting Abstract


Authors: Oeffinger, K. C.; Stratton, K.; Hudson, M. M.; Leisenring, W.; Howell, R. M.; Wolden, S. L.; Constine, L. S.; Diller, L.; Henderson, T. O.; Sklar, C. A.; Nathan, P. C.; Castellino, S. M.; Barnea, D.; Smith, S. A.; Armstrong, G. T.; Robison, L. L.
Abstract Title: Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: A report from the Childhood Cancer Survivor Study (CCSS)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 552s
Language: English
ACCESSION: WOS:000442916003499
DOI: 10.1200/JCO.2018.36.15_suppl.10510
PROVIDER: wos
Notes: Meeting Abstract: 10510 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles A Sklar
    322 Sklar
  2. Suzanne L Wolden
    560 Wolden
Related MSK Work